9th Circ. Urged To Revive Prostate Supplement Labeling Row
A purchaser of an allegedly misbranded treatment for a prostate disease has urged the Ninth Circuit to revive his proposed class action against the supplement maker, saying the allegations do not...To view the full article, register now.
Already a subscriber? Click here to view full article